Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Bone metastasis as a prognostic factor in breast cancer patients with liver metastasis given OK-432-combined adoptive immunotherapy via the hepatic arteryN Kan, S Yamasaki, H Kodama, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Sequential immunotherapy using interleukin-1 followed by interleukin-2 of ascitic MOPC104E-bearing miceT Harada, N Kan, T Okino, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy]N Kan, T Okino, K Satoh, et al.Cardiovascular Research|April 1, 1992
Consequences of opiate agonist and antagonist in myocardial ischaemia suggest a role of endogenous opioid peptides in ischaemic heart diseaseA Y Lee, Y T Chen, M N Kan, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapyK Satoh, N Kan, T Okino, et al.Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|September 1, 1995
Malignant lymphoma arising in the duodenum combined with gastric lymphoma and early gastric cancer: a case reportN Uyama, N Kan, K Inoue, et al.Cancer Research|October 1, 1990
Effect of heat treatment on tumor cells and antitumor effector cellsK Mise, N Kan, T Okino, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytomaN Kan, T Okino, M Nakanishi, et al.Bioorganicheskaia Khimiia|December 14, 2004
[Acyclic nucleoside analogues. III. Synthesis of new 2',3'-dideoxy-2',3'-didehydronucleoside analogues]I A Vasilenko, D V Shamshin, A V Tsytovich, et al.Human Cell|September 1, 1988
[Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes]N Kan, T Okino, M Nakanishi, et al.Pageof 8